UC Davis Health
Cancer Center

Industry & Investigator | UC Davis Comprehensive Cancer Center

For Industry and Investigator Partners

Cancer center
  • Cancer Moonshot Initiative recipients
  • Cancer therapeutics program includes a cohesive group of scientists focused on target identification, drug discovery, development and translation to clinical trials.
  • Research core capabilities in combinatorial chemistry, animal imaging, molecular pharmacology and immune monitoring
  • Largest mouse biology program in the U.S.
  • Innovation groups comprised of basic and translational scientists and multi-disciplinary clinician researchers focused on translating laboratory discoveries to patient treatments
  • To collaborate in basic science: Office of Research

  • First of its kind, formal research partnership with Lawrence Livermore National Laboratory (LLNL)
  • Partnership with Jackson Laboratories with Sacramento campus being the location of their mouse-derived tumor xenografts repository
  • Home of the Explorer Project, an NCI-funded whole-body PET imaging development program
  • GMP facility on Sacramento campus
  • California National Primate Research Center on the Davis campus

  • Conducts 50+ clinical trials per year including first-in-human and cellular therapies
  • Trials in solid tumors and hematological malignancies
  • Enrolls 150+ patient per year to phase I trials
  • Ability to perform serial biopsies and pharmacokinetics
  • Dedicated phase I infusion space
  • The Sacramento Citywide Oncology Phase I (SCOPE) Program is a unique academic-community program with oncologists participating from:
    • Dignity Health
    • Kaiser Permanente
    • Sutter Health
    • Sierra Hematology & Oncology
    • UC Davis Comprehensive Cancer Center (all patients are treated in the phase I unit at UC Davis)

  • Conducts 150+ Phase I-III clinical trials per year
  • Conducts investigator-initiated, federal, and industry trials
  • Continuous federal funding for phase I and II trials through the NCI UM1 mechanism
  • Lead Academic Partner Site (LAPS) for the NCI National Clinical Trials Network (NCTN)
  • Engaged community network of sites through the Cancer Care Network
  • Large Health Disparities Program with special emphasis on Native American, Asian and Hispanic population access to clinical trials
  • For clinical research sponsors, email potential studies to HS-CancerOCRStartup. Confidentiality disclosure agreement, assessment of PI interest, feasibility questionnaires, and site qualification visits are facilitated through the OCR Startup team.

  • 50+ staff members with expertise in regulatory, clinical and data management, financial analysis, and compliance
  • Multi-site clinical trial monitoring and Quality assurance program
  • Contract service lines
  • Correlative laboratory with rapid on-site processing, storage, and shipping
  • Cancer center-dedicated IDS Pharmacy embedded within infusion center
  • Protocol development and IND management
  • 90-day activation timelines for institutional and industry trials

For translational and basic research, visit Office of Research

For clinical research, submit study offers to email [email protected]. Confidentiality disclosure agreements, assessment of PI interest, feasibility questionnaires and site qualification visits are facilitated through this team.

Other Helpful Links

SCOPE Community Partners

OSZAR »